What does Cancer Research Horizons invest in?
Cancer Research Horizons invests most often at Seed and Series A (100% of the rounds on record), in sectors such as Medical Devices, Diagnostics and In Vitro Diagnostics.

United Kingdom · Investor
Last cheque observed Sep 2026; 4 cheques on record.
Deploying nowVC firm
3 cheques in the last 12 months
Mostly Seed and Series A: 100% of its rounds
Every round we can evidence, newest first4 appearances
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The investors most often in the same rounds as Cancer Research Horizons. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Cancer Research Horizons put money into.
Cancer Research Horizons invests most often at Seed and Series A (100% of the rounds on record), in sectors such as Medical Devices, Diagnostics and In Vitro Diagnostics.
4 investments on record, 3 of them in the last 12 months. The most recent was in Sept 2026.
Its most recent investments on record: 52North (Seed, Sept 2026), Laigo Bio (Seed, Apr 2026) and Trogenix Ltd (Series A, Oct 2025).
The median round it joins is $9.9M.
Yes: it is actively investing, with 3 investments in the last 12 months.
Most often Angelini Ventures (2 rounds together), Argobio Studio (2 rounds together) and Curie Capital (2 rounds together).
Cancer Research Horizons is a VC firm based in London, United Kingdom.
Cancer Research Horizons was founded in 2002.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it